US Bancorp
LTRN icon

US Bancorp’s Lantern Pharma LTRN Stock Holding History

US Bancorp’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,000
Closed -$22K – 4178
2021
Q3 		$22K Hold
2,000
– – ﹤0.01% 3085
2021
Q2 		$29K Hold
2,000
– – ﹤0.01% 2941
2021
Q1 		$36K Buy
+2,000
New +$35.1K ﹤0.01% 2747
2020
Q4 		– Sell
-200
Closed -$4K – 3839
2020
Q3 		$4K Hold
200
– – ﹤0.01% 3361
2020
Q2 		$3K Buy
+200
New +$2.59K ﹤0.01% 3437

Other funds holding LTRN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LCM
Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return

US Bancorp's LTRN Position: Q4 2021 in Review

US Bancorp sold out of Lantern Pharma (LTRN) in Q4 2021, closing a stake of 2,000 shares — an estimated $22K sold.

US Bancorp first reported a position in LTRN in Q2 2020 and held it in 5 quarters. The position peaked at $36K in Q1 2021. 33 funds tracked by Wall St. Rank hold LTRN as of Q4 2021.

  • US Bancorp reported no remaining Lantern Pharma position as of Q4 2021 after selling out during the quarter.
  • US Bancorp sold 2,000 Lantern Pharma shares in Q4 2021, an estimated $22K.
  • US Bancorp first reported a position in Lantern Pharma in Q2 2020 and held it in 5 quarters.
  • US Bancorp's Lantern Pharma position peaked at $36K in Q1 2021.
  • 33 funds tracked by Wall St. Rank held Lantern Pharma as of Q4 2021.

Based on US Bancorp's 13F filing for Q4 2021, filed 11 Feb 2022.